AMY FARLETT: Open Payments
NPI 1275903171 · SODDY DAISY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 42 payments from 13 companies in 2025. Trend: 2023 $427 · 2024 $869 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $171 |
| Otsuka America Pharmaceutical, Inc. | 5 | $103 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| ABBVIE INC. | 5 | $87 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Lundbeck LLC | 3 | $71 |
| Abbott Laboratories | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| PFIZER INC. | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
Products named: REXULTI, Auvelity, Ozempic, VRAYLAR, Rybelsus, AIRSUPRA, FREESTYLE LIBRE 3, CAPLYTA.
Industry payments across TN — which companies pay providers there.
